133 related articles for article (PubMed ID: 17460714)
1. Assessment of single versus twice daily dosing of ramipril by ambulatory blood pressure monitoring in patients similar to those included in the HOPE study.
Goyal D; Chong AY; Watson RL; Prasad N; Watson RD
J Hum Hypertens; 2007 Jul; 21(7):525-30. PubMed ID: 17460714
[TBL] [Abstract][Full Text] [Related]
2. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
[TBL] [Abstract][Full Text] [Related]
3. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
4. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial.
White WB; Cleveland JM; Rolleri RL;
J Hum Hypertens; 2008 Aug; 22(8):559-68. PubMed ID: 18463672
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy.
Svensson P; de Faire U; Sleight P; Yusuf S; Ostergren J
Hypertension; 2001 Dec; 38(6):E28-32. PubMed ID: 11751742
[TBL] [Abstract][Full Text] [Related]
6. Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE.
Gerstein HC
Diabetes Metab Res Rev; 2002; 18 Suppl 3():S82-5. PubMed ID: 12324991
[TBL] [Abstract][Full Text] [Related]
7. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
Lüders S; Schrader J; Berger J; Unger T; Zidek W; Böhm M; Middeke M; Motz W; Lübcke C; Gansz A; Brokamp L; Schmieder RE; Trenkwalder P; Haller H; Dominiak P;
J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027
[TBL] [Abstract][Full Text] [Related]
8. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
Dolan E; Stanton AV; Thom S; Caulfield M; Atkins N; McInnes G; Collier D; Dicker P; O'Brien E;
J Hypertens; 2009 Apr; 27(4):876-85. PubMed ID: 19516185
[TBL] [Abstract][Full Text] [Related]
9. [Ramipril effects on 24 hour profile of blood pressure in patients with mild and moderate hypertension].
Kukushkin SK; Lebedev AV; Manoshkina EM; Shamarin VM
Ter Arkh; 1998; 70(9):69-71. PubMed ID: 9821232
[TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of ramipril 10 mg in patients at high risk of cardiovascular events: an observational study.
Hathial M
Indian Heart J; 2008; 60(3):200-4. PubMed ID: 19240307
[TBL] [Abstract][Full Text] [Related]
11. The smoothness of blood pressure control of ramipril in essential hypertensive Thai patients evaluation by 24-hour ambulatory blood pressure monitoring.
Uchaipichat V; Koanantakul B; Suthisisang C
J Med Assoc Thai; 2008 Sep; 91(9):1468-77. PubMed ID: 18843880
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.
Bosch J; Lonn E; Pogue J; Arnold JM; Dagenais GR; Yusuf S;
Circulation; 2005 Aug; 112(9):1339-46. PubMed ID: 16129815
[TBL] [Abstract][Full Text] [Related]
13. Large prospective study of ramipril in patients with hypertension. CARE Investigators.
Kaplan NM; Sproul LE; Mulcahy WS
Clin Ther; 1993; 15(5):810-8. PubMed ID: 8269447
[TBL] [Abstract][Full Text] [Related]
14. A study of the efficacy of felodipine given once or twice daily in the management of elderly hypertensive patients.
Morgan T; Morgan O; Anderson A
J Hum Hypertens; 1996 Mar; 10(3):193-7. PubMed ID: 8733039
[TBL] [Abstract][Full Text] [Related]
15. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension.
Uresin Y; Taylor AA; Kilo C; Tschöpe D; Santonastaso M; Ibram G; Fang H; Satlin A
J Renin Angiotensin Aldosterone Syst; 2007 Dec; 8(4):190-8. PubMed ID: 18205098
[TBL] [Abstract][Full Text] [Related]
17. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
Hermida RC; Ayala DE; Khder Y; Calvo C
Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
[TBL] [Abstract][Full Text] [Related]
18. Safety and tolerability of ramipril 10 mg in patients at high risk of cardiovascular events: an observational study.
Hathial M
J Indian Med Assoc; 2008 Jul; 106(7):468-70, 480. PubMed ID: 18975506
[TBL] [Abstract][Full Text] [Related]
19. Tolerability of ramipril 10 mg daily in high-risk cardiovascular patients in Taiwan: experience from Kaohsiung Medical University Chung-Ho Memorial Hospital.
Chu CS; Cheng KH; Lee KT; Lin TH; Lee ST; Su HM; Voon WC; Sheu SH; Lai WT
Kaohsiung J Med Sci; 2005 Nov; 21(11):511-6. PubMed ID: 16358553
[TBL] [Abstract][Full Text] [Related]
20. CORD: COmparsion of Recommended Doses of ACE inhibitors and angiotensin II receptor blockers.
Spinar J; Vítovec J; Soucek M; Dusek L; Pavlík T;
Vnitr Lek; 2009 May; 55(5):481-8. PubMed ID: 19514614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
